Kolexia
Segondy Michel
Pharmacien
Hôpital Saint-Éloi
Montpellier, France
90 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à papillomavirus Infections à VIH Tumeurs du col de l'utérus Dysplasie du col utérin Infections à polyomavirus Co-infection Condylomes acuminés Infections à Chlamydia Ecchymose

Industries

ViiV Healthcare
1 collaboration(s)
Dernière en 2018
Pfizer
1 collaboration(s)
Dernière en 2018
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Does exposure to different menstrual products affect the vaginal environment?
Molecular ecology   04 octobre 2022
Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case report.
IDCases   19 août 2022
Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies.
The lancet. HIV   30 juillet 2021
Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
PLoS medicine   04 mars 2021
Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
Journal of medical virology   15 février 2021
Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota.
AIDS (London, England)   25 janvier 2021
HPV cervical infections and serological status in vaccinated and unvaccinated women.
Vaccine   07 novembre 2020
Human coronaviruses.
Revue francophone des laboratoires : RFL   31 octobre 2020
Covid-19 Nouvelle vague.
Revue francophone des laboratoires : RFL   31 octobre 2020
Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
Women & health   26 octobre 2020